Novartis 2,000 job cuts in US result of patent ending, new drug demand fall

BASEL, SWITZERLAND – Novartis will be cutting close to 2,000 jobs in the US, in New Jersey, as the result of an expected fall in demand for a relatively new medicine and the expiry of the patent for another, the company announced Friday 13 January in Basel. The sales force will lose 1,630 jobs and […]